Peter, 

Appreciate your response. 
Shyam Bhimani




  

CONFIDENTIALITY NOTICE: The contents of this email message and any attachments 
are intended solely for the addressee(s) and may contain confidential and/or 
privileged information and may be legally protected from disclosure.

-----Original Message-----
From: Peter Abramowitsch <pabramowit...@gmail.com> 
Sent: Tuesday, January 18, 2022 9:19 AM
To: dev@ctakes.apache.org
Subject: Re: Ctakes + UMLS dictionary

** WARNING: This email originated from outside of Target RWE. **


As distributed, it contains the mappings of cuis to 2015 snomed and rxnorm 
vocabularies.  It does not contain ICD 9 or 10 mappings.  But creating a custom 
dictionary is a normal aspect of any serious installation. This is how you can 
incorporate more recent versions of the umls and other vocabularies.  See the 
ctakes dictionary creator for more information.

On Tue, Jan 18, 2022, 7:36 AM Shyam Bhimani <sbhim...@targetrwe.com> wrote:

> Hello,
>
>
>
> When I dig little deep I found below information on cTAKES wiki. Does 
> it mean default clinical pipeline uses 2015 version of SNOWMED, 
> RxNorm, ICD9, ICD10? Please advise.
>
>
>
>
>
> Shyam Bhimani
>
>
>
> *From:* Shyam Bhimani <sbhim...@targetrwe.com>
> *Sent:* Thursday, January 13, 2022 8:10 PM
> *To:* dev@ctakes.apache.org
> *Subject:* Ctakes + UMLS dictionary
>
>
>
> *** **WARNING:* This email originated from outside of Target RWE. ****
>
>
>
> Hello,
>
>
>
> I am new to cTAKES and having hard time understanding what 
> year/version dictionary (SNOMED-CT, RxNorm, ICD9 etc) is being used by 
> ctakes default clinical pipeline?
>
> I have some medication names that are not being picked up by cTAKES eg 
> dupilumab, dupixent so I am trying to understand why. Please advise.
>
>
>
> TIA
>
>
>
> Shyam Bhimani
>
> *Software Engineer*
>
>
>
> *Target RWE *
>
> 5001 S Miami Blvd, Suite 100
>
> Durham, NC 27703
>
> sbhim...@targetrwe.com
>
> C: (817) 323-0632
>
>
>
>
> <https://nam12.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww
> .targetrwe.com%2F&amp;data=04%7C01%7C%7Cff820d39bb904a065f6308d9da9e4f
> 74%7Cd09f6c4846d241f380993e0f7df7a48e%7C1%7C0%7C637781195763008088%7CU
> nknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1ha
> WwiLCJXVCI6Mn0%3D%7C3000&amp;sdata=v32v0ofWwBBwwdTm%2BeykdKCDz20ItDE6f
> 2GMNZJva8k%3D&amp;reserved=0>
>
>
>
>
>
> [image: Title: LinkedIn - Description: image of LinkedIn icon]
> <https://nam12.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Ftargetrwe%2F&amp;data=04%7C01%7C%7Cff820d39bb904a065f6308d9da9e4f74%7Cd09f6c4846d241f380993e0f7df7a48e%7C1%7C0%7C637781195763008088%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000&amp;sdata=QhFxUBhxaOjUSe%2BFXnCBNI33FQAplp1iuohoTKI2ZOE%3D&amp;reserved=0>[image:
> Title: Twitter - Description: image of Twitter icon] 
> <https://nam12.safelinks.protection.outlook.com/?url=https%3A%2F%2Ftwi
> tter.com%2FTargetRWE&amp;data=04%7C01%7C%7Cff820d39bb904a065f6308d9da9
> e4f74%7Cd09f6c4846d241f380993e0f7df7a48e%7C1%7C0%7C637781195763008088%
> 7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik
> 1haWwiLCJXVCI6Mn0%3D%7C3000&amp;sdata=57q7UxHrIS9tZg43%2Bh3uvUyogvohWG
> 9YBLPblgos1b4%3D&amp;reserved=0>
>
>
>
>
> *CONFIDENTIALITY NOTICE: The contents of this email message and any 
> attachments are intended solely for the addressee(s) and may contain 
> confidential and/or privileged information and may be legally 
> protected from disclosure.*
>
>
>

Reply via email to